120 related articles for article (PubMed ID: 20210915)
1. Selection and dosing of medications for management of diabetes in patients with advanced kidney disease.
Reilly JB; Berns JS
Semin Dial; 2010; 23(2):163-8. PubMed ID: 20210915
[TBL] [Abstract][Full Text] [Related]
2. [Oral hypoglycemic drugs in chronic kidney disease: which limitations in the clinical setting].
Granata A; Insalaco M; Di Nicolò P; Scarfia VR; Russo L; D'anna G; Lentini P; Fiorini F; Fatuzzo P
G Ital Nefrol; 2014; 31(1):. PubMed ID: 24671840
[TBL] [Abstract][Full Text] [Related]
3. Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease.
Snyder RW; Berns JS
Semin Dial; 2004; 17(5):365-70. PubMed ID: 15461745
[TBL] [Abstract][Full Text] [Related]
4. Drug interactions with oral antidiabetic agents: pharmacokinetic mechanisms and clinical implications.
Tornio A; Niemi M; Neuvonen PJ; Backman JT
Trends Pharmacol Sci; 2012 Jun; 33(6):312-22. PubMed ID: 22475684
[TBL] [Abstract][Full Text] [Related]
5. Effects of insulin and other antihyperglycaemic agents on lipid profiles of patients with diabetes.
Chaudhuri A; Dandona P
Diabetes Obes Metab; 2011 Oct; 13(10):869-79. PubMed ID: 21569185
[TBL] [Abstract][Full Text] [Related]
6. Overview of Data Concerning the Safe Use of Antihyperglycemic Medications in Type 2 Diabetes Mellitus and Chronic Kidney Disease.
Roussel R; Lorraine J; Rodriguez A; Salaun-Martin C
Adv Ther; 2015 Nov; 32(11):1029-64. PubMed ID: 26581749
[TBL] [Abstract][Full Text] [Related]
7. Oral antidiabetic therapy in patients with heart disease. A cardiologic standpoint.
Fisman EZ; Tenenbaum A; Motro M; Adler Y
Herz; 2004 May; 29(3):290-8. PubMed ID: 15167955
[TBL] [Abstract][Full Text] [Related]
8. When diet fails: insulin and oral hypoglycemic agents as alternatives for the management of gestational diabetes mellitus.
Langer O
J Matern Fetal Neonatal Med; 2002 Apr; 11(4):218-25. PubMed ID: 12375674
[TBL] [Abstract][Full Text] [Related]
9. Antidiabetic effects of dipeptidyl peptidase-IV inhibitors and sulfonylureas in streptozotocin-nicotinamide-induced mildly diabetic mice.
Matsuyama-Yokono A; Tahara A; Nakano R; Someya Y; Shiraki K; Hayakawa M; Shibasaki M
Metabolism; 2009 Mar; 58(3):379-86. PubMed ID: 19217455
[TBL] [Abstract][Full Text] [Related]
10. Use of noninsulin antidiabetic medications in hospitalized patients.
Kopecky C
Crit Care Nurs Clin North Am; 2013 Mar; 25(1):39-53. PubMed ID: 23410645
[TBL] [Abstract][Full Text] [Related]
11. Management of glycemia in patients with diabetes mellitus and CKD.
Lubowsky ND; Siegel R; Pittas AG
Am J Kidney Dis; 2007 Nov; 50(5):865-79. PubMed ID: 17954300
[No Abstract] [Full Text] [Related]
12. Influence of glycemic control on the development of diabetic cardiovascular and kidney disease.
Saha SA; Tuttle KR
Cardiol Clin; 2010 Aug; 28(3):497-516. PubMed ID: 20621253
[TBL] [Abstract][Full Text] [Related]
13. [Use of oral hypoglycemic agents in patients with chronic kidney failure].
Libardi F; Sirolli V; Cappelli P; Bonomini M
G Ital Nefrol; 2009; 26(6):679-85. PubMed ID: 19918750
[TBL] [Abstract][Full Text] [Related]
14. Dipeptidyl peptidase IV inhibitors and the incretin system in type 2 diabetes mellitus.
Langley AK; Suffoletta TJ; Jennings HR
Pharmacotherapy; 2007 Aug; 27(8):1163-80. PubMed ID: 17655515
[TBL] [Abstract][Full Text] [Related]
15. Incretin enhancers and the evolution of antihyperglycemic therapy in type 2 diabetes.
Inzucchi SE
Endocrinol Metab Clin North Am; 2007 Dec; 36 Suppl 2 Incretin():2-17. PubMed ID: 18405144
[No Abstract] [Full Text] [Related]
16. Therapeutic approach of type 2 diabetes mellitus with GLP-1 based therapies.
Penfornis A; Borot S; Raccah D
Diabetes Metab; 2008 Feb; 34 Suppl 2():S78-90. PubMed ID: 18640590
[TBL] [Abstract][Full Text] [Related]
17. Rosiglitazone/glimepiride (Avandaryl) for diabetes.
Med Lett Drugs Ther; 2006 Mar; 48(1230):22-4. PubMed ID: 16538189
[No Abstract] [Full Text] [Related]
18. Pharmacokinetic and toxicological considerations for the treatment of diabetes in patients with liver disease.
Scheen AJ
Expert Opin Drug Metab Toxicol; 2014 Jun; 10(6):839-57. PubMed ID: 24669954
[TBL] [Abstract][Full Text] [Related]
19. Oral antidiabetic agents in type 2 diabetes.
Levetan C
Curr Med Res Opin; 2007 Apr; 23(4):945-52. PubMed ID: 17407651
[TBL] [Abstract][Full Text] [Related]
20. Insulin therapy in renal disease.
Iglesias P; Díez JJ
Diabetes Obes Metab; 2008 Sep; 10(10):811-23. PubMed ID: 18248491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
